Despite newly implemented tariffs, the manufacturer says it was profitable in Q1 of 2025, but a greater impact on its operations looms later this year. 

The Massachusetts senator is asking buyer Sycamore Partners for certain assurances, including that it won’t saddle the struggling pharmacy chain with even more debt and indiscriminately close retail locations. 

In a 7-2 vote, the Supreme Court affirmed the formula used by the federal government to calculate Disproportionate Share Hospital (DSH) payments is legal and consistent with the law passed by Congress. 

A leaked report from Ernst & Young says President Donald Trump’s proposed 25% tariff on drugs would stifle domestic manufacturing and force the industry to take on an additional $51 billion in annual costs.

AI shines in radiology when tasked with interpreting images of patients whose odds of illness are either very high or very low. In these cases, the technology could help mitigate burnout and supplement staffing. 

The Department of Health and Human Services is refusing to allocate funds meant to support state and local healthcare initiatives, as the money stemmed from now-defunct COVID-19 control efforts. A coalition of municipalities is suing to lift the block. 

The mobile power units of certain HeartMate 3 and HeartMate II LVADs have been experiencing “sudden, unexpected performance issues” such as turning on, off or even restarting with no warning. These issues can potentially be fatal, according to an alert shared by the FDA.

The Florida governor claims the money was not part of a settlement the state made with Centene, and that the insurer donated the cash as a “cherry on top.”